Charles River Laboratories (NYSE: CRL) net income
Charles River Laboratories reported a net loss of $144.3m for fiscal 2025; in fiscal 2024 it reported a net profit of $22.2m. Earnings per share were −$2.91.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$144.3m | −750.1% | −3.6% | −$2.91 |
| 2024 | $22.2m | −95.3% | 0.5% | $0.20 |
| 2023 | $474.6m | −2.4% | 11.5% | $9.27 |
| 2022 | $486.2m | +24.4% | 12.2% | $9.57 |
| 2021 | $391.0m | +7.3% | 11.0% | $7.77 |
| 2020 | $364.3m | +44.6% | 12.5% | $7.35 |
| 2019 | $252.0m | +11.3% | 9.6% | $5.17 |
| 2018 | $226.4m | +83.5% | 10.0% | $4.72 |
| 2017 | $123.4m | −20.3% | 6.6% | $2.60 |
| 2016 | $154.8m | — | 9.2% | $3.29 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Charles River Laboratories
- How much did Charles River Laboratories earn in fiscal 2025?
- Charles River Laboratories reported a net loss of $144.3m for fiscal 2025. In fiscal 2024 it reported a net profit of $22.2m.
- What are the earnings per share of Charles River Laboratories?
- They were −$2.91 in fiscal 2025, compared with $0.20 in fiscal 2024.
- What was the most profitable year for Charles River Laboratories?
- Of its last 10 fiscal years, fiscal 2022, with $486.2m.
- Where do the figures for Charles River Laboratories come from?
- From the annual report (Form 10-K) that Charles River Laboratories files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Charles River Laboratories files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Charles River Laboratories: the Charles River Laboratories page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.